Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
Coastal Financial
CCB
$721M
| $911K | ﹤0.01% |
59,804
-15,945
| -21% | -$246K |
|
2602
Rocket Pharmaceuticals
RCKT
$415M
| $911K | ﹤0.01% |
61,462
-80,041
| -57% | -$1.33M |
|
2603
SiriusPoint
SPNT
$2.78B
| $910K | ﹤0.01% |
94,443
-226
| -0.2% | -$2.42K |
|
|
MB
2604
CALL
DELISTED
MINDBODY, Inc. Class A Common Stock
MB
| $910K | ﹤0.01% |
25,000
-15,000
| -38% | -$456K |
|
|
BBT
2605
Beacon Financial Corp
BBT
$2.63B
| $909K | ﹤0.01% |
+33,709
| New | +$1.13M |
|
2606
iShares US Healthcare Providers ETF
IHF
$1.23B
| $908K | ﹤0.01% |
+27,495
| New | +$1.04M |
|
2607
iShares US Real Estate ETF
IYR
$4.67B
| $908K | ﹤0.01% |
12,110
-20,499
| -63% | -$1.61M |
|
|
MRNS
2608
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $906K | ﹤0.01% |
78,961
+34,208
| +76% | +$692K |
|
2609
Thomson Reuters
TRI
$45.2B
| $905K | ﹤0.01% |
17,781
-52,596
| -75% | -$2.82M |
|
2610
CALL
Rithm Capital
RITM
$5.68B
| $904K | ﹤0.01% |
+63,600
| New | +$1.07M |
|
2611
Tootsie Roll Industries
TR
$3.11B
| $904K | ﹤0.01% |
34,289
-20,796
| -38% | -$531K |
|
2612
Vipshop
VIPS
$6.8B
| $902K | ﹤0.01% |
165,170
-1,431,501
| -90% | -$7.7M |
|
|
FNCB
2613
DELISTED
FNCB Bancorp Inc. Common Stock
FNCB
| $902K | ﹤0.01% |
106,877
-12,532
| -10% | -$116K |
|
|
CIO
2614
DELISTED
City Office REIT
CIO
| $901K | ﹤0.01% |
87,869
-32,209
| -27% | -$361K |
|
2615
PUT
Union Pacific
UNP
$184B
| $898K | ﹤0.01% |
+6,500
| New | +$963K |
|
2616
Scholar Rock
SRRK
$7.09B
| $896K | ﹤0.01% |
+39,012
| New | +$882K |
|
2617
First Business Financial Services
FBIZ
$586M
| $893K | ﹤0.01% |
45,759
-4,656
| -9% | -$96.5K |
|
2618
Skyworks Solutions
SWKS
$9.89B
| $893K | ﹤0.01% |
13,327
+2,922
| +28% | +$226K |
|
2619
iShares MSCI USA Value Factor ETF
VLUE
$9.77B
| $893K | ﹤0.01% |
12,308
+6,945
| +129% | +$562K |
|
|
ARC
2620
DELISTED
ARC Document Solutions, Inc.
ARC
| $893K | ﹤0.01% |
435,501
-283,566
| -39% | -$692K |
|
2621
Northern Trust Morningstar Global Upstream Natural Resources ETF
GUNR
$7.38B
| $891K | ﹤0.01% |
+30,445
| New | +$956K |
|
2622
Lindsay Corp
LNN
$1.16B
| $891K | ﹤0.01% |
9,253
-24,399
| -73% | -$2.38M |
|
2623
Pool Corp
POOL
$6.77B
| $888K | ﹤0.01% |
+5,971
| New | +$894K |
|
2624
NewMarket
NEU
$8.56B
| $886K | ﹤0.01% |
2,150
-2,767
| -56% | -$1.1M |
|
|
HRC
2625
CALL
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $886K | ﹤0.01% |
+10,000
| New | +$908K |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.